other_material
confidence high
sentiment positive
materiality 0.85
KALA BIO launches AI infrastructure platform; licenses Researgency from Younet AI
KALA BIO, Inc.
- Exclusive worldwide license to Researgency platform for biotech field; initial 12-month term with renewal options.
- Consideration includes up to $530k cash and issuance of 5 million shares of KALA common stock per term.
- Company holds an irrevocable option to acquire Younet AI for $55 million, exercisable during the term.
- Strategic pivot: KALA will deploy on-premises, data-sovereign AI for biotech clients targeting recurring revenue.
- KALA will first deploy on its own MSC-S and KPI-012 data; preliminary findings expected in 12 months.